
Sign up to save your podcasts
Or


Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.

135 Listeners

318 Listeners

494 Listeners

66 Listeners

31 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

3,338 Listeners

196 Listeners

44 Listeners

22 Listeners

364 Listeners

189 Listeners

43 Listeners

0 Listeners